Laden…
2-[(2-ethoxyphenoxy)methyl]morpholine
Viloxazine is an atypical antidepressant that primarily acts as a selective norepinephrine reuptake inhibitor and additionally modulates serotonergic receptors. It is used for the treatment of depression and ADHD. The substance exhibits a moderate side effect profile and a low potential for abuse. Due to its mechanism of action, Viloxazine affects both the noradrenergic and serotonergic systems in the central nervous system.
Class
Noradrenalin-Wiederaufnahmehemmer
Pharmacological context
Mechanism
Viloxazin wirkt als Noradrenalin-Wiederaufnahmehemmer und hat auch eine...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
Designations
IUPAC: 2-[(2-ethoxyphenoxy)methyl]morpholine
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology translation in progress
English prose is being expanded. The German version currently has more detail.
Reported range 200–400 mg
Oral
| Tier | Dosage |
|---|---|
| Light | 100 mg |
| Reported | 200–400 mg |
| Strong | 600 mg |
Oral
Onset
1–2 weeks
Peak
4–6 weeks
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Nebenwirkungen umfassen Schläfrigkeit, Übelkeit und Veränderungen im Blutdruck.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.